Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-290486

Chief Medical Officer sold 6,000 shares at $22.95 ($137,700)

  • Chief Medical Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Janku Filip Chief Medical Officer 2026-06-29 Option exercise 10b5-1 +6,000 $7.56 $45,360 65,992 D: show line 1 in the form
Janku Filip Chief Medical Officer 2026-06-29 Sale 10b5-1 −6,000 $22.95 $137,700 59,992 D: show line 2 in the form
Open-market sales · 6,000 sh · avg $22.95 · $137,700

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Janku Filip Chief Medical Officer 2026-06-29 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 60,000 D: show line 3 in the form
Loading xslF345X06/ownership.xml…